Hans_BMTProgram's profile picture. Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.

Hans Messner Allogeneic BMT Program

@Hans_BMTProgram

Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.

Закреплено

Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).

Hans_BMTProgram's tweet image. Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).
Hans_BMTProgram's tweet image. Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).
Hans_BMTProgram's tweet image. Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).
Hans_BMTProgram's tweet image. Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).

Hans Messner Allogeneic BMT Program сделал(а) репост

📢 Now out in @BrJHaem 🎊🎉 Our latest work from the @pmcancercentre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up) onlinelibrary.wiley.com/doi/10.1111/bj…

nihardesai89's tweet image. 📢 Now out in @BrJHaem 🎊🎉

Our latest work from the @pmcancercentre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up)
 onlinelibrary.wiley.com/doi/10.1111/bj…

Hans Messner Allogeneic BMT Program сделал(а) репост

An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell transplant and caregivers can learn about the process in this eLearning series. @Hans_BMTProgram pmcancerclasses.ca/course/view.ph…

PMCancerEdu's tweet image. An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell transplant and caregivers can learn about the process in this eLearning series. @Hans_BMTProgram pmcancerclasses.ca/course/view.ph…

Hans Messner Allogeneic BMT Program сделал(а) репост

📢 Published in @ASTCT_Journal 🎉 Using a large dataset (@CIBMTR + @Hans_BMTProgram), we show that ATG + PTCy may alleviate the ⤴️GvHD risk associated with female donor-to-male recipient MUD transplants 🙌🏽 astctjournal.org/article/S2666-…

nihardesai89's tweet image. 📢 Published in @ASTCT_Journal 🎉

Using a large dataset (@CIBMTR + @Hans_BMTProgram), we show that ATG + PTCy may alleviate the ⤴️GvHD risk associated with female donor-to-male recipient MUD transplants 🙌🏽
 astctjournal.org/article/S2666-…

Hans Messner Allogeneic BMT Program сделал(а) репост

🎉 Out now in @ASTCT_Journal 🙌🏽 We compare two conditioning regimens for second allogeneic transplant after primary graft failure! Interesting results 👇🏽 DM me for the PDF! sciencedirect.com/science/articl… @Hans_BMTProgram

nihardesai89's tweet image. 🎉 Out now in @ASTCT_Journal 🙌🏽

We compare two conditioning regimens for second allogeneic transplant after primary graft failure!

Interesting results 👇🏽
DM me for the PDF!

sciencedirect.com/science/articl… @Hans_BMTProgram

Hans Messner Allogeneic BMT Program сделал(а) репост

Our work is now out in @ASTCT_Journal We looked into the association between cumulative cyclosporine exposure over the first 90 days (AUC90) post-HCT and key transplant outcomes, including graft failure and relapse. @Hans_BMTProgram astctjournal.org/article/S2666-…


Hans Messner Allogeneic BMT Program сделал(а) репост

Delighted to share our latest publication on the impact of conditioning intensity in younger AML patients receiving dual T-cell depletion for GVHD prophylaxis. #Hematology #BMT @AhmedAlNughmush @Hans_BMTProgram doi.org/10.1111/ejh.14…


Hans Messner Allogeneic BMT Program сделал(а) репост

Proud moment at the CTTC Conference! Here’s a roundup of phenomenal poster presentations from our team at @Hans_BMTProgram @UHN and @pmcancercentre , tackling real-world challenges in transplant medicine and GVHD. #CTTC2025 #HCT #GVHD #HemeTwitter 1/10


Hans Messner Allogeneic BMT Program сделал(а) репост

🚨 New Study Alert! @nihardesai89 @Haemophage @IvanPasic Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromes—a rare and challenging group of hematologic neoplasms. 🧵👇


Hans Messner Allogeneic BMT Program сделал(а) репост

Excellent thread summarising key findings of our latest publication from @pmcancercentre 👇🏽 DM me if you want the PDF 🙌🏽 onlinelibrary.wiley.com/doi/10.1111/ej… #MedTwitter @SergioRdzRdz @Hans_BMTProgram @Haemophage

nihardesai89's tweet image. Excellent thread summarising key findings of our latest publication from @pmcancercentre 👇🏽

DM me if you want the PDF 🙌🏽

onlinelibrary.wiley.com/doi/10.1111/ej… #MedTwitter @SergioRdzRdz @Hans_BMTProgram @Haemophage

🚨 New Study Alert! @nihardesai89 @Haemophage @IvanPasic Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromes—a rare and challenging group of hematologic neoplasms. 🧵👇



Hans Messner Allogeneic BMT Program сделал(а) репост

The abstract titles for #ASCO25 are out 🙌🏽 We asked 2 questions: 1. Can we ⤵️the PTCy dose in MUDs? 2. What's the outcome of patients who are alive 2 yr post transplant? We'll answer those questions at the oral abstract session @ASCO #MedTwitter @Hans_BMTProgram

nihardesai89's tweet image. The abstract titles for #ASCO25 are out 🙌🏽

We asked 2 questions:
1. Can we ⤵️the PTCy dose in MUDs?

2. What's the outcome of patients who are alive 2 yr post transplant?

We'll answer those questions at the oral abstract session @ASCO

#MedTwitter @Hans_BMTProgram

Hans Messner Allogeneic BMT Program сделал(а) репост

Exciting news from a dear patient. Thank you for sharing your journey with us.

After 4 weeks in @pmcancercentre @UHN and 21 days post stem cell transplant from my sister, I am discharged to home and now an out-patient. Excellent care - the recovery journey continues - sincere thanks to family and friends for your ongoing love and support

FergDevins's tweet image. After 4 weeks in @pmcancercentre @UHN and 21 days post stem cell transplant from my sister, I am discharged to home and now an out-patient. Excellent care - the recovery journey continues - sincere thanks to family and friends for your ongoing love and support


Hans Messner Allogeneic BMT Program сделал(а) репост

🎉🎉🎉Excited to have TWO ORAL PRESENTATIONS at #ASCO25 in Chicago! As always, I'm thankful to @Haemophage and the team at @pmcancercentre for the phenomenal mentorship 🙌🏽 Looking forward to a great discussion and meeting some solid oncologists 🤣 #MedTwitter

nihardesai89's tweet image. 🎉🎉🎉Excited to have TWO ORAL PRESENTATIONS at #ASCO25 in Chicago! 

As always, I'm thankful to @Haemophage and the team at @pmcancercentre for the phenomenal mentorship 🙌🏽

Looking forward to a great discussion and meeting some solid oncologists 🤣

#MedTwitter

Hans Messner Allogeneic BMT Program сделал(а) репост

🎉🎉 200 ALLOGENEIC transplants in a year is no mean feat 💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽 I am proud to be a part of this amazing team 💪🏽 P.S. We are on track for 250 this year 🙌🏽 #MedTwitter @Haemophage @Hans_BMTProgram @PanktiMehta24 @SergioRdzRdz @NicoGagelmann

Huge milestone! Today our centre infused the 200th AlloBMT for this fiscal year. That’s 200 Allogeneic Stem Cell Transplants THIS YEAR (overall we’re >5k) and we’re still going strong! A new record! #AlloBMT #bmtsm @pmcancercentre @UHN @nihardesai89 @bradwouters @thePMCF



Huge milestone! Today our centre infused the 200th AlloBMT for this fiscal year. That’s 200 Allogeneic Stem Cell Transplants THIS YEAR (overall we’re >5k) and we’re still going strong! A new record! #AlloBMT #bmtsm @pmcancercentre @UHN @nihardesai89 @bradwouters @thePMCF


Hans Messner Allogeneic BMT Program сделал(а) репост

Wow! What a phenomenal team we work with at @Hans_BMTProgram ! It truly takes a village to achieve such a monumental goal.

Этот твит больше недоступен.

Hans Messner Allogeneic BMT Program сделал(а) репост

This eLearning series explains the process of allogeneic stem cell transplant to treat sickle cell disease. pmcancerclasses.ca/course/view.ph… @Hans_BMTProgram

PMCancerEdu's tweet image. This eLearning series explains the process of allogeneic stem cell transplant to treat sickle cell disease. pmcancerclasses.ca/course/view.ph…
@Hans_BMTProgram

Hans Messner Allogeneic BMT Program сделал(а) репост

I am pleased to present 3 posters and chair a session at @TheEBMT annual meeting in Florence 🙌🏽 Can't wait to meet the mad lot we call @TheEBMT_Trainee 🤣🤣 @Hans_BMTProgram #MedTwitter

nihardesai89's tweet image. I am pleased to present 3 posters and chair a session at @TheEBMT annual meeting in Florence 🙌🏽

Can't wait to meet the mad lot we call @TheEBMT_Trainee 🤣🤣

@Hans_BMTProgram #MedTwitter

Hans Messner Allogeneic BMT Program сделал(а) репост

An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell transplant and their loved ones can learn about the process in this eLearning series. pmcancerclasses.ca/course/view.ph… @Hans_BMTProgram

PMCancerEdu's tweet image. An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell transplant and their loved ones can learn about the process in this eLearning series. pmcancerclasses.ca/course/view.ph…
@Hans_BMTProgram

Hans Messner Allogeneic BMT Program сделал(а) репост

In 2024, we performed close to 250 allogeneic transplants!! Thank you to our patients and every member of the exceptional team 🙏🏽 Bring on 2025 💪🏽 #MedTwitter @Hans_BMTProgram

nihardesai89's tweet image. In 2024, we performed close to 250 allogeneic transplants!!

Thank you to our patients and every member of the exceptional team 🙏🏽 

Bring on 2025 💪🏽

#MedTwitter @Hans_BMTProgram

Loading...

Something went wrong.


Something went wrong.